Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB04869> ?p ?o ?g. }
Showing items 1 to 15 of
15
with 100 items per page.
- drugbank:DB04869 type drugbank_vocabulary:Drug assertion.
- drugbank:DB04869 label "Olcegepant [drugbank:DB04869]" assertion.
- drugbank:DB04869 seeAlso DB04869 assertion.
- drugbank:DB04869 description "Boehringer Ingelheim Pharmaceuticalsâ olcegepant (BIBN 4096) is a selective Calcitonin Gene-Related Peptide (CGRP) antagonist, a new class of drugs in development for the treatment of acute migraine attacks. Olcegepant is undergoing phase II trials in Europe and the US, with preliminary results suggesting that CGRP antagonists may represent a potential new approach to the treatment of migraine." assertion.
- drugbank:DB04869 identifier "drugbank:DB04869" assertion.
- drugbank:DB04869 title "Olcegepant" assertion.
- drugbank:DB04869 drugbank_vocabulary:x-pubchemsubstance pubchem.substance:3819966 assertion.
- drugbank:DB04869 drugbank_vocabulary:x-pubchemcompound pubchem.compound:3025955 assertion.
- drugbank:DB04869 drugbank_vocabulary:x-chemspider chemspider:2291583 assertion.
- drugbank:DB04869 drugbank_vocabulary:x-cas cas:204697-65-4 assertion.
- drugbank:DB04869 drugbank_vocabulary:drugbank-id "DB04869" assertion.
- drugbank:DB04869 bio2rdf_vocabulary:x-identifiers.org DB04869 assertion.
- drugbank:DB04869 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB04869" assertion.
- drugbank:DB04869 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB04869 bio2rdf_vocabulary:identifier "DB04869" assertion.